Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions.

Usansky H, Au Yeung S, Li S, Marbury T, Lawitz E, Kayali Z, Stein DS.

Open source

DOI
10.1007/s40262-025-01614-0
Published
2026-01-26
Container
Clin Pharmacokinet
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40262-025-01614-0,
  title = {Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions.},
  author = {Usansky H and  Au Yeung S and  Li S and  Marbury T and  Lawitz E and  Kayali Z and  Stein DS.},
  year = {2026},
  journal = {Clin Pharmacokinet},
  doi = {10.1007/s40262-025-01614-0},
  url = {https://doi.org/10.1007/s40262-025-01614-0}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions.
AU  - Usansky H
AU  -  Au Yeung S
AU  -  Li S
AU  -  Marbury T
AU  -  Lawitz E
AU  -  Kayali Z
AU  -  Stein DS.
PY  - 2026
JO  - Clin Pharmacokinet
DO  - 10.1007/s40262-025-01614-0
UR  - https://doi.org/10.1007/s40262-025-01614-0
ER  - 

APA

H, U., S, A. Y., S, L., T, M., E, L., Z, K., & DS., S. (2026). Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions.. Clin Pharmacokinet. https://doi.org/10.1007/s40262-025-01614-0

Source records